Last update 23 Jan 2025

Anti CD147 CAR-T(Xijing Hospital)

Overview

Basic Info

Drug Type
Autologous CAR-T
Synonyms-
Target
BSG
Mechanism
BSG inhibitors(Basigin inhibitors), Cell replacements, Gene transference
Therapeutic Areas
NeoplasmsDigestive System DisordersNervous System Diseases+ [1]
Active Indication-
Inactive Indication
Advanced Hepatocellular CarcinomaRecurrent GlioblastomaRecurrent Malignant Glioma
Originator Organization
Xijing Hospital
Active Organization-
Inactive Organization
Xijing Hospital
Drug Highest PhasePendingPhase 1
First Approval Date-
Regulation-
Login to view timeline

Related

3
Clinical Trials associated with Anti CD147 CAR-T(Xijing Hospital)
ChiCTR2100045721
/ RecruitingEarly Phase 1IIT
An exploratory clinical study to access the safety and efficacy of CD147-CART for relapsed or refractory T-cell non-Hodgkin's lymphoma
NCT04045847
/ Unknown statusEarly Phase 1IIT
A Clinical Study to Investigate the Safety, Tolerance and Efficacy Evaluation of Single-centre, Open-label of Local Treatment of CD147-CART in Recurrent Glioblastoma.
NCT03993743
/ Unknown statusPhase 1IIT
An Open-label, Dose Escalation Clinical Study to Access the Safety and Clinical Activity of CD147-targeted CART by Hepatic Artery Infusions for Very Advanced Hepatocellular Carcinoma
100 Clinical Results associated with Anti CD147 CAR-T(Xijing Hospital)
Login to view more data
100 Translational Medicine associated with Anti CD147 CAR-T(Xijing Hospital)
Login to view more data
100 Patents (Medical) associated with Anti CD147 CAR-T(Xijing Hospital)
Login to view more data
100 Deals associated with Anti CD147 CAR-T(Xijing Hospital)
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Recurrent Malignant GliomaPhase 1
CN
Xijing Hospital
30 May 2019
Advanced Hepatocellular CarcinomaPhase 1
CN
Xijing Hospital
27 May 2019
Recurrent GlioblastomaPreclinical
CN
Xijing Hospital
30 May 2019
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free